| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/02/2001 | EP1095038A1 Antagonists of gonadotropin releasing hormone |
| 05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/02/2001 | EP1095021A1 Quinoline derivatives |
| 05/02/2001 | EP1095003A1 Cytokine production and tyrosine kinase inhibitors |
| 05/02/2001 | EP1094832A1 Therapeutic use of uncoupling protein-hhfcw60 |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094823A2 Use of alpha-d-glucans for promoting cutaneous wound and ulcer healing |
| 05/02/2001 | EP1094813A2 Use of piperine for treating skin pigmentation disorders |
| 05/02/2001 | EP1094800A2 PEPTIDYL-PROLYL $i(CIS)-TRANS ISOMERASE INHIBITORS AND USES THEREFOR |
| 05/02/2001 | EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 05/02/2001 | EP1094781A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | CN1293562A Method of reducing cellulite in mammalian skin |
| 05/02/2001 | CN1293064A Medicine for treating psoriasis and its preparing process |
| 05/02/2001 | CN1293062A Chinese medicine for treating alopecia |
| 05/02/2001 | CN1293061A Process for preparing face beautifying medicines and its product |
| 05/02/2001 | CN1293059A Application of safflower oil in preparing medicines |
| 05/02/2001 | CN1293058A Exterior-applied medicine for treating burn |
| 05/02/2001 | CN1293042A Propolis honey and its preparing process |
| 05/02/2001 | CN1293038A Composition for preparing medicines, beautifying and cosmetics and its application |
| 05/02/2001 | CN1293034A Spot-removing beautifying face cream |
| 05/02/2001 | CN1293012A Aloe-meat sausage |
| 05/02/2001 | CN1065133C External used paste for treatment of pimple |
| 05/01/2001 | US6225494 Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225342 Use of calendula glycosides for the treatment of psoriasis |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224885 Barrier cream comprising hexamethylenetetramine or derivative thereof |
| 05/01/2001 | US6224850 Antiwrinkle cosmetic/pharmaceutical compositions comprising iridaceae extracts |
| 05/01/2001 | CA2203464C Antimycotic ectoparasiticidal product - external use |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029061A1 Novel fusidic acid derivatives |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029041A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029009A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | WO2001028993A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028600A1 Conveyance of anti-infective activity to wound dressings |
| 04/26/2001 | WO2001028599A1 Isoalloxazine derivatives to neutralize biological contaminants |
| 04/26/2001 | WO2001028589A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/26/2001 | WO2001028586A1 Method of treating fibrosis |
| 04/26/2001 | WO2001028571A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 04/26/2001 | WO2001028565A1 Remedies for pigmentation and melanocyte proliferation inhibitors |
| 04/26/2001 | WO2001028543A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
| 04/26/2001 | WO2001028516A2 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | WO2001028509A1 Depilatories and agents for external use |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2001028491A2 Method and composition for the treatment of dermatologic diseases |
| 04/26/2001 | WO2001028338A2 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 04/26/2001 | WO2001028336A1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/26/2001 | WO2000074703A3 Therapeutic agent comprising a botulinum neurotoxin |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19951161A1 Producing an agent for the control or cure of epithelial warts comprises biological decomposition of e.g. a potato |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19949252A1 Superfizielles therapeutisches System zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen Superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2387840A1 Tyrosine kinase inhibitors |
| 04/26/2001 | CA2387819A1 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | CA2387786A1 Treatment of eosinophil associated pathologies by modulating pkc-.delta. activity |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387348A1 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 04/26/2001 | CA2387034A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | CA2386149A1 Allosteric sites on muscarinic receptors |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093803A2 Cosmetic composition comprising antagonist of the neuropeptide Y receptor |
| 04/25/2001 | EP1093786A1 Skin cosmetic composition containing kidney bean extracts |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093380A2 Component b as angiogenic agent in combination with human growth factors |
| 04/25/2001 | EP1093374A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292699A Method of treating skin irritation |
| 04/25/2001 | CN1292682A Skin normalizing agents |
| 04/25/2001 | CN1292673A Topical liquid composition for promoting hair growth and process of manufacturing thereof |
| 04/25/2001 | CN1292268A Medicine for curing tinea unguium |
| 04/25/2001 | CN1064847C Seahorse pain-eliminating ointment and its preparing method |
| 04/25/2001 | CN1064841C 骨伤酊 Orthopedics tincture |